Overview
COVID variant vaccines are immunizations developed or adapted to maintain protection against evolving variants of SARS-CoV-2, the virus that causes COVID-19. As the virus replicates, mutations accumulate, particularly in the spike glycoprotein that mediates cell entry and is the principal target of vaccine-induced immunity, and some changes can reduce the effectiveness of immunity raised against earlier strains. This drives the scientific need to track viral evolution and to update or design vaccines accordingly. Research relevant to this topic includes the molecular and evolutionary characterization of SARS-CoV-2 and its relationship to other coronaviruses, algorithmic prediction of possible spike mutations, and the immunological effects of spike-protein variation on interferon and cytokine responses. It also connects to the broader epidemiology of the pandemic, including models of transmission and outbreak risk and estimates of the immunization required to limit spread, as well as the information environment surrounding vaccines. Understanding variant vaccines therefore requires linking genomic surveillance to immunology and to population-level transmission dynamics. Sub-areas include viral mutation and spike-protein evolution, genomic surveillance and variant identification, the immunology of vaccine-induced protection against variants, and the modeling of vaccination strategy. By aligning vaccine design with the changing virus, variant vaccines aim to sustain immunity and reduce severe disease as SARS-CoV-2 continues to evolve.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Molecular Evolutionary Characteristics of the 2019 Novel Coronavirus (SARS-CoV-2) Contracted by Tunisian Citizens : Comparison and Relationship to Other Human and Animal Coronaviruses Based on Spike Glycoprotein-Coding Gene Sequences Analysis
An Algorithm to Predict the Possible SARS-CoV-2 Mutations
The Novel Coronavirus 2019 (COVID-19): A Narrative Review
Dynamics of Infections and Number of Vaccines Needed to Avoid Covid-19 in Europe
Marginal SARS-CoV-2 Spike Protein Increases Interferon and Balances Cytokine Gene Expression
A Data Mining Methodology for Detecting Conspiracy Theories from Scientific Articles: The Covid-19 Case
Animals in the COVID-19 Era: Between Being a source, Victims, or Maybe our Hope to Overcome it!
SARS-Cov-2 Viral Kinetics in Mild COVID-19 Patients Treated with Chloroquine Regimens or Standard of Care
Models and data Analysis of the Outbreak Risk of COVID-19
Use of Immune Modulator Interferon-Gamma to Support Combating COVID-19 Pandemic
Prevalence of Covid 19 in Students Attended Al-Dora Family Medical Center for Covid 19 Test
How this research is being cited
The 12 articles above have been cited 20 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2024 · German Journal of Pharmaceuticals and Biomaterials
-
Satadal Das et al. · 2023 · International Journal of Applied Biology
-
2023 · Frontiers in Medicine
-
2023 · Applied Mathematics and Nonlinear Sciences
-
2023 · Frontiers in Medicine
-
2022 · International Journal of Clinical Virology
-
2022 · International Journal of Clinical Virology
-
2022 · Applied Mathematics and Nonlinear Sciences
A sample of recent works citing this journal's research on Covid Variant Vaccines, linking to each citing work.